The Patent Finder

Terms ending in 2029

Gilead Sciences, Inc.

Every in-force patent on Gilead Sciences, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,334,295Pyrimidine Derivatives as HIV Reverse Transcriptase Inhibitors
In force
 · High confidence
Korea Research Institute of Chemical TechnologyIn forceHigh confidence
US 8,193,192Heterocyclic FXR Binding Compounds
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 8,569,478Modified 4`-NUCLEOSIDES as Antiviral Agents
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 8,217,155Metabolites and Derivatives of Ambrisentan
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 7,964,580Nucleoside Phosphoramidate Prodrugs
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 7,968,544Modulators of Toll-Like Receptor 7
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 7,842,672Phosphonate Inhibitors of HCV
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 8,318,6821'SUBSTITUTED Carba-Nucleoside Analogs for Antiviral Treatment
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US RE46,7621'-Substituted Carba-Nucleoside Analogs for Antiviral Treatment
In force
 · Low confidence
Gilead Sciences, Inc.In forceLow confidence
US 8,338,435Substituted PYRIDO(3,2-D) Pyrimidines and Pharmaceutical Compositions for Treating Viral Infections
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
30 more term ends in 2029 · Pro
10 of 40 patents shown. Soonest term end first, then patent number.
Pro members see all 40.
Upgrade to Pro
39 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited